| 2021 | "3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy | CANCER RESEARCH |
| 2018 | Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells. | CANCER RESEARCH |
| 2009 | Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation
| CANCER RESEARCH |
| 2012 | AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer.
| CANCER RESEARCH |
| 2000 | Anti-Vascular Endothelial Growth Factor Treatment Augments Tumor Radiation Response under Normoxic or Hypoxic Conditions.
| Cancer Research |
| 2022 | Antibody-Drug Conjugates: A New Addition to the Treatment Landscape of EGFR-Mutant Non-Small Cell Lung Cancer | CANCER RESEARCH |
| 2014 | Antitumor Effects in Hepatocarcinoma of Isoform-Selective Inhibition of HDAC2. | CANCER RESEARCH |
| 2003 | Autotaxin Hydrolyzes Sphingosylphosphorylcholine to Produce the Regulator of Migration, Sphingosine-1-Phosphate
| CANCER RESEARCH |
| 2012 | Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide | CANCER RESEARCH |
| 2009 | Central role of c-Myc during malignant conversion in human hepatocarcinogenesis
| CANCER RESEARCH |
| 2014 | Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression | CANCER RESEARCH |
| 2004 | Cytoplasmic Mislocalization of p27Kip1 Protein Is Associated with Constitutive Phosphorylation of Akt or Protein Kinase B and Poor Prognosis in Acute Myelogenous Leukemia
| CANCER RESEARCH |
| 2010 | Definition of Ubiquitination Modulator COP1 as a Novel Therapeutic Target in Human Hepatocellular Carcinoma
| CANCER RESEARCH |
| 2019 | Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis | CANCER RESEARCH |
| 2023 | Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer | CANCER RESEARCH |
| 2018 | Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors. | CANCER RESEARCH |
| 2009 | Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
| CANCER RESEARCH |
| 2001 | Frameshift Mutations at Coding Mononucleotide Repeats of the hRAD50 Gene in Gastrointestinal Carcinomas with Microsatellite Instability
| CANCER RESEARCH |
| 2017 | HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells | CANCER RESEARCH |
| 2016 | HSPB1 Inhibits the Endothelial-to-Mesenchymal Transition to Suppress Pulmonary Fibrosis and Lung Tumorigenesis. | CANCER RESEARCH |
| 2010 | Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma
| CANCER RESEARCH |
| 2009 | Identification of potential driver genes in human liver carcinoma by genomewide screening
| CANCER RESEARCH |
| 2008 | Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene
| CANCER RESEARCH |
| 2004 | Insulin-Like Growth Factor-Binding Protein 3 Induces Caspase-Dependent Apoptosis through a Death Receptor-Mediated Pathway in MCF-7 Human Breast Cancer Cells
| CANCER RESEARCH |
| 2018 | Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis | CANCER RESEARCH |
| 2012 | KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A
| CANCER RESEARCH |
| 2013 | Loss of TBK1 Induces Epithelial–Mesenchymal Transition in the Breast Cancer Cells by ERα Downregulation | CANCER RESEARCH |
| 2014 | Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation | CANCER RESEARCH |
| 2019 | MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers | CANCER RESEARCH |
| 2016 | NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells
| CANCER RESEARCH |
| 2018 | O-GlcNAcylation of the Tumor Suppressor FOXO3 Triggers Aberrant Cancer Cell Growth | CANCER RESEARCH |
| 2003 | Overexpression of High Mobility Group Box 1 in Gastrointestinal Stromal Tumors with KIT Mutation
| CANCER RESEARCH |
| 2013 | Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma
| CANCER RESEARCH |
| 2007 | Proteomics-Based Identification of Proteins Secreted in Apical Surface Fluid of Squamous Metaplastic Human Tracheobronchial Epithelial Cells Cultured by Three-Dimensional Organotypic Air-Liquid Interface Method
| CANCER RESEARCH |
| 2005 | Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels
| CANCER RESEARCH |
| 2007 | Relaxin-Expressing, Fiber Chimeric Oncolytic Adenovirus Prolongs Survival of Tumor-Bearing Mice
| CANCER RESEARCH |
| 2024 | Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer | CANCER RESEARCH |
| 2007 | Silibinin Sensitizes Human Glioma Cells to TRAIL-Mediated Apoptosis via DR5 Up-regulation and Down-regulation of c-FLIP and Survivin
| CANCER RESEARCH |
| 2003 | Site-directed Mutations in the Tumor-associated Cytokine, Autotaxin, Eliminate Nucleotide Phosphodiesterase, Lysophospholipase D, and Motogenic Activities
| CANCER RESEARCH |
| 2004 | Suppression of Colorectal Cancer Liver Metastasis and Extension of Survival by Expression of Apolipoprotein(a) Kringles
| CANCER RESEARCH |
| 2005 | Suppression of Progression and Metastasis of Established Colon Tumors in Mice by Intravenous Delivery of Short Interfering RNA Targeting KITENIN, a Metastasis-Enhancing Protein
| CANCER RESEARCH |
| 2018 | Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis | CANCER RESEARCH |
| 2014 | Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance | CANCER RESEARCH |
| 2002 | The bioenergic signature of cancer: A marker of tumor progression | CANCER RESEARCH |
| 2020 | The Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression | CANCER RESEARCH |
| 2016 | Tumor Suppressor HIPK2 Regulates Malignant Growth via Phosphorylation of Notch1 | CANCER RESEARCH |
| 2001 | Vascular Endothelial Growth Factor (VEGF)-C Differentially Affects Tumor Vascular Function and Leukocyte Recruitment: Role of VEGF-Receptor 2 and Host VEGF-A 1
| CANCER RESEARCH |
